← Open Payments lookup

DINA PIERRE-GRAY: Open Payments

NPI 1639743131 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,131 in 79 payments from 9 companies in 2025. Trend: 2023 $354 · 2024 $2,313 · 2025 $4,131

Food & beverage: $2,851Consulting: $1,280
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.16$1,865
Neurocrine BioSciences, Inc.16$726
ABBVIE INC.7$417
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$404
Teva Pharmaceuticals USA, Inc.9$244
Alkermes, Inc.7$232
Janssen Pharmaceuticals, Inc5$125
Otsuka America Pharmaceutical, Inc.5$103
Otsuka Pharmaceutical Development & Commercialization, Inc.1$15

Products named: INGREZZA, COBENFY, VRAYLAR, CAPLYTA, ARISTADA, UZEDY, INVEGA SUSTENNA, AUSTEDO XR.

Industry payments across IL — which companies pay providers there.